Prospective Observational Study Of Geniculate Artery Embolization For Symptomatic Knee Osteoarthritis In A Cancer Population

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorM.D. Anderson Cancer Center

About this trial

To explore associations with demographics/clinical factors; assess trajectories via annual follow-up; evaluate healthcare utilization and barriers; oversample \>10-year survivors.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥40 years with no upper age restriction, provided performance status permits procedural candidacy

Symptomatic mild-to-severe knee osteoarthritis (Kellgren-Lawrence grade 2-4) on radiographs within 6 months of enrollment

Chronic knee pain (NRS ≥4/10) for ≥3 months despite conservative treatment including steroid injections, physical therapy, and/or analgesic medications

Inadequate candidate for or refusal of surgical intervention (e.g., total knee arthroplasty) due to cancer-related comorbidities, ongoing treatment, or participants preference

Disqualifiers

Active joint infection or suspected septic arthritis

Life expectancy <6 months

Prior knee arthroplasty in the index knee

Coagulopathy or contraindications to angiography

Trial population

UT MD Anderson Cancer Center

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • SOC (Standard of care)

    Other intervention

    Patients scheduled for standard of care

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Numeric Rating Scale Questionnaire

Time frame
Through study completion; an average of 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.